Idiopathic pericarditis and pericardial effusion in children: Contemporary epidemiology and management

Journal of the American Heart Association

Volumn 3, Issue 6, 2014, Pages

  Shakti, Divya ^a   Hehn, Rebecca ^a   Gauvreau, Kimberly ^a   Sundel, Robert P ^a   Newburger, Jane W ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Colchicine; Pediatric; Pericardial disease; Pericardial effusion; Pericarditis; Pericardium

Indexed keywords

ACETYLSALICYLIC ACID; COLCHICINE; CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT; ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ARTICLE; CHILD; FEMALE; HEART TAMPONADE; HOSPITAL READMISSION; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC PERICARDITIS; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; PERICARDIECTOMY; PERICARDIOCENTESIS; PERICARDIOTOMY; PERICARDITIS; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; AGE; AGE DISTRIBUTION; CLINICAL TRIAL; FACTUAL DATABASE; HOSPITAL PATIENT; INFANT; MULTICENTER STUDY; PRESCHOOL CHILD; RISK FACTOR; SEX DIFFERENCE; SEX RATIO; TIME; TREATMENT OUTCOME; UNITED STATES; VIROLOGY; YOUNG ADULT;

ADOLESCENT; AGE DISTRIBUTION; AGE FACTORS; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INPATIENTS; LENGTH OF STAY; MALE; PATIENT READMISSION; PERICARDIAL EFFUSION; PERICARDIECTOMY; PERICARDIOCENTESIS; PERICARDITIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84939461053     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.114.001483     Document Type: Article

References (20)

1. Kuhn B, Peters J, Marx GR, Breitbart RE. Etiology, management, and outcome of pediatric pericardial effusions. Pediatr Cardiol. 2008;29:90-94.
2. Mok GC, Menahem S. Large pericardial effusions of inflammatory origin in childhood. Cardiol Young. 2003;13:131-136.
3. Ratnapalan S, Brown K, Benson L. Children presenting with acute pericarditis to the emergency department. Pediatr Emerg Care. 2011;27:581-585.
4. Imazio M, Bobbio M, Cecchi E, Demarie D, Demichelis B, Pomari F, Moratti M, Gaschino G, Giammaria M, Ghisio A, Belli R, Trinchero R. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation. 2005;112:2012-2016.
5. Imazio M, Bobbio M, Cecchi E, Demarie D, Pomari F, Moratti M, Ghisio A, Belli R, Trinchero R. Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med. 2005;165:1987-1991.
6. Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmüller R, Adler Y, Tomkowski WZ, Thiene G, Yacoub MH. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J. 2004;25:587-610.
7. Imazio M, Demichelis B, Parrini I, Cecchi E, Demarie D, Ghisio A, Belli R, Bobbio M, Trinchero R. Management, risk factors, and outcomes in recurrent pericarditis. Am J Cardiol. 2005;96:736-739.
8. Fowler NO. Recurrent pericarditis. Cardiol Clin. 1990;8:621-626.
9. Raatikka M, Pelkonen PM, Karjalainen J, Jokinen EV. Recurrent pericarditis in children and adolescents: report of 15 cases. J Am Coll Cardiol. 2003;42:759-764.
10. Yazigi A, Abou-Charaf LC. Colchicine for recurrent pericarditis in children. Acta Paediatr. 1998;87:603-604.
11. Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg. 2002;123:110-118.
12. Lotrionte M, Biondi-Zoccai G, Imazio M, Castagno D, Moretti C, Abbate A, Agostoni P, Brucato AL, Di Pasquale P, Raatikka M, Sangiorgi G, Laudito A, Sheiban I, Gaita F. International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences. Am Heart J. 2010;160:662-670.
13. Imazio M, Cecchi E, Demichelis B, Ierna S, Demarie D, Ghisio A, Pomari F, Coda L, Belli R, Trinchero R. Indicators of poor prognosis of acute pericarditis. Circulation. 2007;115:2739-2744.
14. Ghelani SJ, Spaeder MC, Pastor W, Spurney CF, Klugman D. Demographics, trends, and outcomes in pediatric acute myocarditis in the United States, 2006 to 2011. Circ Cardiovasc Qual Outcomes. 2012;5:622-627.
15. Frisancho-Kiss S, Davis SE, Nyland JF, Frisancho JA, Cihakova D, Barrett MA, Rose NR, Fairweather D. Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. J Immunol. 2007;178:6710-6714.
16. Frisancho-Kiss S, Nyland JF, Davis SE, Frisancho JA, Barrett MA, Rose NR, Fairweather D. Sex differences in coxsackievirus B3-induced myocarditis: IL-12Rbeta1 signaling and IFN-gamma increase inflammation in males independent from STAT4. Brain Res. 2006;1126:139-147.
17. Lyden DC, Olszewski J, Feran M, Job LP, Huber SA. Coxsackievirus B-3-induced myocarditis. Effect of sex steroids on viremia and infectivity of cardiocytes. Am J Pathol. 1987;126:432-438.
18. Imazio M, Brucato A, Cemin R, Ferrua S, Maggiolini S, Beqaraj F, Demarie D, Forno D, Ferro S, Maestroni S, Belli R, Trinchero R, Spodick DH, Adler Y; ICAP Investigators. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2013;369:1522-1528.
19. Imazio M, Brucato A, Cemin R, Ferrua S, Belli R, Maestroni S, Trinchero R, Spodick DH, Adler Y; CORP (COlchicine for Recurrent Pericarditis) Investigators. Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med. 2011;155: 409-414.
20. Kallinich T, Haffner D, Rudolph B, Schindler R, Canaan-Kühl S, Keitzer R, Burmester GR, Roesen-Wolff A, Roesler J. "Periodic fever" without fever: two cases of non-febrile TRAPS with mutations in the TNFRSF1A gene presenting with episodes of inflammation or monosymptomatic amyloidosis. Ann Rheum Dis. 2006;65: 958-960.